Renaissance Capital logo

I Bella Perfect Filed Terms, Nasdaq: IBL

Operates three aesthetic medical clinics in Malaysia.

Industry: Health Care

Latest Trade: ()

First Day Return:

Return from IPO:

Industry: Health Care

Through I Bella and its two subsidiaries, IBI and IBSA, we are principally involved in the provision of aesthetic medical services in Malaysia, including facial and skin treatments, as well as body and face contouring. We also sell skincare products as part of our business. We operate three aesthetic medical clinics located in the central and southern regions of Malaysia, namely at Kuala Lumpur (“Bella Clinic”), Selangor (“Bella Clinic Iconic”), and Johor (“Bella Clinic Inspire”). Established in 2013, Bella Clinic serves as our headquarters, with the later establishment of Bella Clinic Iconic in 2023 and Bella Clinic Inspire in 2024, as we grew and expanded our operations. In our aesthetic medical service offerings, we specialize in the performance of non-invasive and minimally invasive procedures. We do not offer invasive procedures such as plastic surgery. The non-invasive procedures focus on enhancing skin and body care without penetration of the skin, including those procedures relating to skin care, slimming, body care, and wellness. The minimally invasive procedures involve treatments that target deeper layers of the skin or that use injections, including skin tightening, botulinum toxin (BOTOX® or “Botox”) injections, filler injections, and laser treatments.
more less
IPO Data
IPO File Date 12/30/2025
Offer Price
Price Range $4.00 - $6.00
Offer Shares (mm) 1.9
Deal Size ($mm) $9
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date
Offer Price
Price Range $4.00 - $6.00
Offer Shares (mm) 1.9
Deal Size ($mm) $9
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Cathay Securities
Company Data
Headquarters Kuala Lumpur, Malaysia
Founded 2012
Employees at IPO 51
Website bellaclinic.my

I Bella Perfect (IBL) Performance